Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments



Rating:

Share or cite this content

Citations should be made in the following way:
V. Carriero (Orbassano, Italy), F. Bertolini (Orbasssano, Italy), E. Arrigo (Orbasssano, Italy), F. Ricciardolo (Orbassano, Italy). Eosinophilic refractory inflammation in OCS-dependent severe asthma. 1103

Member's Comments

No comment yet.

Related content which might interest you: Late-onset persistent eosinophilic severe asthma Source: International Congress 2015 – Severe asthma phenotyping Year: 2015 Eosinophilic inflammation and asthma control Source: Annual Congress 2009 - Inflammation and airways Year: 2009 Benralizumab for severe asthma associated with extra-airway eosinophilic diseases Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Eosinophilic asthma Source: Eur Respir Monogr 2022; 95: 73-99 Year: 2022 Eosinophilic airway inflammation in COPD and asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Severe therapy-resistant asthma Source: International Congress 2016 – PG8 Paediatric asthma Year: 2016 Neutrophilic severe asthma Source: International Congress 2015 – Severe asthma phenotyping Year: 2015 Mepolizumab in real-life treatment of severe eosinophilic asthma Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Asthma exacerbations and eosinophilic inflammation 6 months after treatment with mepolizumab in refractory eosinophilic asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Manifestation of idiopathic chronic eosinophilic pneumonia Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Pathophysiology of non-eosinophilic severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017 Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Source: Eur Respir J 2003; 22: 8-13 Year: 2003 Severe asthma Source: ISSN=ISSN 1810-6838, ISBN=, page=128 Year: 2006 Severe asthma Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019 Severe asthma Source: ERS Lung Science Conference 2016 Year: 2016 Severe asthma Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD Year: 2014 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020